Related references
Note: Only part of the references are listed.CD4+T-CellTranscription Factors in IdiopathicREMSleep Behavior Disorder and Parkinson's Disease
Erika De Francesco et al.
MOVEMENT DISORDERS (2021)
Dopamine receptor D2 on CD4+ T cells is protective against neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease
Zhan Liu et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
Expression of Transcription Factors in CD4+T Cells as Potential Biomarkers of Motor Complications in Parkinson's Disease
Elena Contaldi et al.
JOURNAL OF PARKINSONS DISEASE (2021)
T lymphocyte senescence is attenuated in Parkinson's disease
Antonina Kouli et al.
JOURNAL OF NEUROINFLAMMATION (2021)
T-cell dysregulation is associated with disease severity in Parkinson's Disease
Divisha Bhatia et al.
JOURNAL OF NEUROINFLAMMATION (2021)
CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease
Gregory P. Williams et al.
BRAIN (2021)
Evidence for Peripheral Immune Activation in Parkinson's Disease
Xueping Chen et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease
Katherine E. Olson et al.
EBIOMEDICINE (2021)
Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson's disease
Aaron D. Thome et al.
NPJ PARKINSONS DISEASE (2021)
Increased Tc17 cell levels and imbalance of naive/effector immune response in Parkinson's disease patients in a two-year follow-up: a case control study
Diana D. Alvarez-Luquin et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Altered Actinobacteria and Firmicutes Phylum Associated Epitopes in Patients With Parkinson's Disease
Zhuo Li et al.
FRONTIERS IN IMMUNOLOGY (2021)
The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?
Adina N. MacMahon Copas et al.
FRONTIERS IN NEUROLOGY (2021)
Single-cell transcriptome and TCR profiling reveal activated and expanded T cell populations in Parkinson's disease
Pingping Wang et al.
CELL DISCOVERY (2021)
Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson Disease
Zhaoqi Yan et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
Alpha synuclein deficiency increases CD4+ T-cells pro-inflammatory profile in a Nurr1-dependent manner
Dorit Trudler et al.
JOURNAL OF NEUROCHEMISTRY (2020)
Older patients with IBD might have higher risk of Parkinson's disease
Qian-Yi Wan et al.
GUT (2020)
Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology
Jasper C. A. Broen et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease
Cecilia S. Lindestam Arlehamn et al.
NATURE COMMUNICATIONS (2020)
Relationship between circulating CD4+T lymphocytes and cognitive impairment in patients with Parkinson's disease
Luca Magistrelli et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Bystander CD4+T cells: crossroads between innate and adaptive immunity
Hong-Gyun Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Azathioprine immunosuppression and disease modification in Parkinson's disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol
Julia C. Greenland et al.
BMJ OPEN (2020)
CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease
Jordi Galiano-Landeira et al.
BRAIN (2020)
The risk of Parkinson's disease in inflammatory bowel disease: A systematic review and meta-analysis
Feng Zhu et al.
DIGESTIVE AND LIVER DISEASE (2019)
Th17 cells: a promising therapeutic target for Parkinson's disease?
Iryna Prots et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Immune system and new avenues in Parkinson's disease research and treatment
Ava Nasrolahi et al.
REVIEWS IN THE NEUROSCIENCES (2019)
Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice
Yuki Kishimoto et al.
NEUROMOLECULAR MEDICINE (2019)
Deciphering targets of Th17 cells fate: From metabolism to nuclear receptors
Vinicius de Oliveira Boldrini et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2019)
Intestinal infection triggers Parkinson's disease-like symptoms in Pink1-/- mice
Diana Matheoud et al.
NATURE (2019)
Glatiramer Acetate Reverses Motor Dysfunction and the Decrease in Tyrosine Hydroxylase Levels in a Mouse Model of Parkinson's Disease
Madeline J. Churchill et al.
NEUROSCIENCE (2019)
A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease
R. Lee Mosley et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Gut Inflammation in Association With Pathogenesis of Parkinson's Disease
Qian-Qian Chen et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Regulatory impairment in untreated Parkinson's disease is not restricted to Tregs: other regulatory populations are also involved
Diana D. Alvarez-Luquin et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Abnormal subpopulations of peripheral blood lymphocytes are involved in Parkinson's disease
Congcong Sun et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
The role of regulatory T cells in nervous system pathologies
Samuel S. Duffy et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2018)
Reduced Activated T Lymphocytes (CD4+CD25+) and Plasma Levels of Cytokines in Parkinson's Disease
Natalia Pessoa Rocha et al.
MOLECULAR NEUROBIOLOGY (2018)
Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson's Disease
Annika Sommer et al.
CELL STEM CELL (2018)
Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+Th1/Th2/T17 and Treg in drug-naive and drugtreated patients
Natasa Kustrimovic et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease
Inga Peter et al.
JAMA NEUROLOGY (2018)
Immune cell subset differentiation and tissue inflammation
Pu Fang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
Jens B. Schroeder et al.
FRONTIERS IN NEUROLOGY (2018)
Expanded autologous regulatory T-lymphocyte infusions in ALS A phase I, first-in-human study
Jason R. Thonhoff et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
TH2 cell development and function
Jennifer A. Walker et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Th17 Cells Induce Dopaminergic Neuronal Death via LFA-1/ICAM-1 Interaction in a Mouse Model of Parkinson's Disease
Zhan Liu et al.
MOLECULAR NEUROBIOLOGY (2017)
The immune response to Prevotella bacteria in chronic inflammatory disease
Jeppe Madura Larsen
IMMUNOLOGY (2017)
Parkinson disease-associated LRRK2 G2019S transgene disrupts marrow myelopoiesis and peripheral Th17 response
Jeongho Park et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Parkinson's Disease and Parkinson's Disease Medications Have Distinct Signatures of the Gut Microbiome
Erin M. Hill-Burns et al.
MOVEMENT DISORDERS (2017)
T cells from patients with Parkinson's disease recognize α-synuclein peptides
David Sulzer et al.
NATURE (2017)
The correlation of lymphocyte subsets, natural killer cell, and Parkinson's disease: a meta-analysis
Sen Jiang et al.
NEUROLOGICAL SCIENCES (2017)
Increased abundance of myeloid-derived suppressor cells and Th17 cells in peripheral blood of newly-diagnosed Parkinson's disease patients
Siyuan Chen et al.
NEUROSCIENCE LETTERS (2017)
Peripheral Lymphocyte Subsets as a Marker of Parkinson's Disease in a Chinese Population
Luan Cen et al.
NEUROSCIENCE BULLETIN (2017)
Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial
Howard E. Gendelman et al.
NPJ PARKINSONS DISEASE (2017)
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease
Timothy R. Sampson et al.
CELL (2016)
A critical role for alpha-synuclein in development and function of T lymphocytes
Afshin Shameli et al.
IMMUNOBIOLOGY (2016)
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses
Benjamin Ettle et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model
Annika Sommer et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Dopaminergic Receptors on CD4+T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease
Natasa Kustrimovic et al.
SCIENTIFIC REPORTS (2016)
Clinical correlation of peripheral CD4+-cell sub-sets, their imbalance and Parkinson's disease
Yuhua Chen et al.
MOLECULAR MEDICINE REPORTS (2015)
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
Mike A. Nalls et al.
NATURE GENETICS (2014)
MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration
Carolina Cebrian et al.
NATURE COMMUNICATIONS (2014)
Mitochondrial and cytosolic roles of PINK1 shape induced regulatory T-cell development and function
Gavin I. Ellis et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Immunotherapy of allergic diseases using probiotics or recombinant probiotics
M. S. P. de Azevedo et al.
JOURNAL OF APPLIED MICROBIOLOGY (2013)
GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice
Lisa M. Kosloski et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
CD4+Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson's Disease
Jessica A. Hutter Saunders et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Human leukocyte antigen variation and Parkinson's disease
Andreas Puschmann et al.
PARKINSONISM & RELATED DISORDERS (2011)
Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson's Disease
Ashley D. Reynolds et al.
JOURNAL OF IMMUNOLOGY (2010)
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease
Taye H. Hamza et al.
NATURE GENETICS (2010)
Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease
Vanesa Sanchez-Guajardo et al.
PLOS ONE (2010)
Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease
Ashley D. Reynolds et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo
R Kortekaas et al.
ANNALS OF NEUROLOGY (2005)
Alterations of T-lymphocyte populations in Parkinson disease
Y Baba et al.
PARKINSONISM & RELATED DISORDERS (2005)
Human T regulatory cells can use the perforin pathway to cause autologous target cell death
WJ Grossman et al.
IMMUNITY (2004)
Share Paper
